Investor Presentation • Nov 13, 2024
Investor Presentation
Open in ViewerOpens in native device viewer
Jörg Tewes (CEO) and Jan-Dirk Henrich (CFO)
01 Trading Update 9M 2024 \& Outlook 2024
02 Update on Strategy
03 Q\&A

Jörg Tewes, CEO

Jan-Dirk Henrich, CFO
This presentation contains future-oriented, forward-looking statements ("Forward- looking Statements"), estimates, opinions, projections and forecasts representing the current assessments and views with respect to anticipated future performance of Exasol AG. These assessments, views and Forward-looking Statements are subject to changes. There are uncertain conditions that are for the most part difficult to predict and are beyond the control of Exasol AG. Exasol AG is not under any obligation to publish any information resulting in changes in framework conditions or to publish revised information.
The information in this presentation as well as the Forward-looking Statements are of preliminary and abbreviated nature and may be subject to updating, revision and amendment, and such information may change materially. Neither Exasol AG nor any of its directors, officers, employees, agents or affiliates undertakes or is under any duty to update this presentation or to correct any inaccuracies in any such information which may become apparent or to provide any additional information.
The Forward-looking Statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "aims", "plans", "predicts", "may", "will" or "should" or, in each case, their negative, or other variations or comparable terminology. These Forward-looking Statements include all matters that are not historical facts. They appear in a number of places throughout this presentation and include statements regarding Exasol's intentions, beliefs or current expectations concerning, among other things, Exasol's prospects, growth, strategies, the industry in which it operates and potential or ongoing acquisitions. By their nature, Forward-looking Statements involve significant risks and uncertainties, because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking Statements should not be read as guarantees of future performance or results and will not necessarily be accurate indications of whether or not such results will be achieved.
FINANCIALS 9M 2024
(2024 figures are unaudited)
ARR: $40.4 \mathrm{~m} €$
$(+12 \%$ yoy $)$
Revenue: $29.1 \mathrm{~m} €$
$(+11 \%$ yoy $)$
EBITDA: $1.0 \mathrm{~m} €$
(9M 2023: $-4.1 \mathrm{~m} €^{*}$ )
Liquid Funds: $17.8 \mathrm{~m} €$
(Dec 31, 2023: $13.3 \mathrm{~m} €$ )
Outlook 2024 (substantiated)
ARR Growth:
Up to 10\% (no change)
Revenue growth:
$10-15 \%$ (no change)
EBITDA:
$1.5-2.0 \mathrm{~m} €$
(previously: positive)
Liquid Funds:
$11-13 \mathrm{~m} €$
(previously: $>10 \mathrm{~m} €$ )
In EUR million at const. FX and methodology, in percent, # of customers

In EUR million at const. FX and methodology, in percent

In EUR million at const. FX and methodology, in percent

North America


OpenEngine continuously updates figures as new information becomes available, without a fixed cutoff date.
2024 figures are unaudited
| Revenue | Q3 2024 | Q3 2023 | Change | 9M 2024 | 9M 2023 | Change |
|---|---|---|---|---|---|---|
| - thereof recurring revenue | 9.6 | 8.5 | 1.1 | 29.1 | 26.3 | 2.8 |
| - thereof non-recurring revenue | 9.6 | 8.5 | 1.1 | 29.0 | 25.4 | 3.6 |
| Gross Profit* | 0.0 | 0.0 | 0.0 | 0.1 | 0.9 | $-0.8$ |
| Personnel expenses | 9.3 | 8.1 | 1.2 | 29.3* | 25.7* | 3.6 |
| Training and Recruiting | $-6.5^{ }$ | $-6.6^{ }$ | 0.1 | $-20.2^{ }$ | $-21.5^{ }$ | 1.3 |
| Marketing | $-0.1$ | $-0.2$ | 0.2 | $-0.1$ | $-0.3$ | 0.2 |
| IT infrastructure | $-0.1$ | $-0.5$ | 0.5 | $-0.9$ | $-2.4$ | 1.5 |
| Others (FY 2023: adj.) | $-1.1$ | $-0.6$ | $-0.5$ | $-2.8$ | $-1.8$ | $-1.0$ |
| Total Costs (FY 2023: adj.) | $-1.3$ | $-1.0$ | $-0.3$ | $-4.2$ | $-3.8$ | $-0.4$ |
| EBITDA (FY 2023: adj.) | $-8.9$ | $-8.9$ | 0.0 | $-28.2$ | $-29.9$ | 1.7 |
| 0.4 | $-0.7$ | 1.1 | 1.0 | $-4.1$ | 5.1 |
[^0]
[^0]: *incl. 1.0m EUR (booked in Q2 2024) and 0.9m EUR (booked in Q2 2023) other operating income from granting of R\&D subsidies by ministry of finance
** incl. 0.9 m EUR restructuring expenses in 9 M 2024 (of which ca. 0.1 m in Q 3 ) and 0.7 m EUR restructuring expenses in 9 M 2023 (of which ca. 0.1 m in Q 3 )
In EUR million
2024 figures are unaudited

2024 figures are unaudited

[^0]
[^0]: *incl. short term financial assets
** excl. non-recurring effects from pre-IPO stock programs (until 2024) and excl. effects from capital increase in June 2023
| 2023 | 2024 | |
|---|---|---|
| ARR growth | $18 \%$ | Up to 10\% (unchanged) |
| Revenue Growth | $6 \%$ | $10-15 \%$ (unchanged) |
| EBITDA | $-5.4 \mathrm{~m} €$ (adj.) | $1.5-2.0 \mathrm{~m} €$ (previously: positive) |
| Liquid Funds | $13.3 \mathrm{~m} €$ | $11-13 \mathrm{~m} €$ (previously: $>10 \mathrm{~m} €$ ) |
Exasol's offerings scale to address our customers' pain points. From BI acceleration to full data warehouse solutions, Exasol's products help achieve faster, deeper, and cheaper data analytics

BI Acceleration
"I have a spinning wheel problem with my BI tool."
Consumption Layer
"I have a database performance and/or cost issue."
Data Warehouse
"I need a high-performance data warehouse for my division."
Exasol's high-quality products are the natural choice for all organizations with high performance requirements, particularly those
leveraging on-premises or hybrid set-ups for cost, security, or compliance reasons

In percent

Future strategy is designed to be focused on defensible and sustainable strengths with the goal to return to a dynamic growth on a profitable basis
Exasol will concentrate its GTM focus even more to on-premise and hybrid customers
Market research shows that the on-premise market continues to be a multi-billion dollar market growing in single digit rates
INDICATIVE




Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.